Smooth versus Textured Implant Breast Reconstruction: Patient-Reported Outcomes and Complications.


Journal

Plastic and reconstructive surgery
ISSN: 1529-4242
Titre abrégé: Plast Reconstr Surg
Pays: United States
ID NLM: 1306050

Informations de publication

Date de publication:
01 Nov 2021
Historique:
entrez: 27 10 2021
pubmed: 28 10 2021
medline: 20 1 2022
Statut: ppublish

Résumé

The association between textured surface breast implants and breast implant-associated anaplastic large cell lymphoma has led to an increase in surgical procedures to exchange textured devices to smooth surface implants. Because patient satisfaction is an integral part of breast reconstruction, the purpose of this study was to compare patient-reported outcomes between smooth and textured implant recipients. Patients aged 18 years or older who underwent implant-based postmastectomy breast reconstruction with either smooth or textured devices from 2009 to 2017 and completed the BREAST-Q patient-reported outcome measure following reconstruction were included in this analysis. The primary outcomes of interest were mean and median BREAST-Q scores and postoperative complications. Overall, 1077 patients were included-785 who underwent breast reconstruction with smooth implants and 292 who underwent breast reconstruction with textured implants. No statistical differences were observed between the textured and smooth implant groups for any of the BREAST-Q domain scores at any of the early (3-month) to late (2-year) postoperative time points. Smooth implant recipients reported significantly more rippling (p = 0.003) than textured implant recipients. In contrast, textured implant recipients had a higher rate of cellulitis than smooth implant recipients (p = 0.016). These data suggest that postoperative satisfaction with breasts or health-related quality of life following immediate postmastectomy implant-based breast reconstruction is likely independent of implant surface type. However, smooth breast implants may result in more rippling. The authors' findings represent an important aid in counseling patients who have questions about the risks and benefits of replacing their textured implants with smooth surface devices. Therapeutic, III.

Sections du résumé

BACKGROUND BACKGROUND
The association between textured surface breast implants and breast implant-associated anaplastic large cell lymphoma has led to an increase in surgical procedures to exchange textured devices to smooth surface implants. Because patient satisfaction is an integral part of breast reconstruction, the purpose of this study was to compare patient-reported outcomes between smooth and textured implant recipients.
METHODS METHODS
Patients aged 18 years or older who underwent implant-based postmastectomy breast reconstruction with either smooth or textured devices from 2009 to 2017 and completed the BREAST-Q patient-reported outcome measure following reconstruction were included in this analysis. The primary outcomes of interest were mean and median BREAST-Q scores and postoperative complications.
RESULTS RESULTS
Overall, 1077 patients were included-785 who underwent breast reconstruction with smooth implants and 292 who underwent breast reconstruction with textured implants. No statistical differences were observed between the textured and smooth implant groups for any of the BREAST-Q domain scores at any of the early (3-month) to late (2-year) postoperative time points. Smooth implant recipients reported significantly more rippling (p = 0.003) than textured implant recipients. In contrast, textured implant recipients had a higher rate of cellulitis than smooth implant recipients (p = 0.016).
CONCLUSIONS CONCLUSIONS
These data suggest that postoperative satisfaction with breasts or health-related quality of life following immediate postmastectomy implant-based breast reconstruction is likely independent of implant surface type. However, smooth breast implants may result in more rippling. The authors' findings represent an important aid in counseling patients who have questions about the risks and benefits of replacing their textured implants with smooth surface devices.
CLINICAL QUESTION/LEVEL OF EVIDENCE METHODS
Therapeutic, III.

Identifiants

pubmed: 34705770
doi: 10.1097/PRS.0000000000008411
pii: 00006534-202111000-00004
pmc: PMC9237832
mid: NIHMS1815545
doi:

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

959-967

Subventions

Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States

Informations de copyright

Copyright © 2021 by the American Society of Plastic Surgeons.

Déclaration de conflit d'intérêts

Disclosure:Dr. Pusic is a codeveloper of the BREAST-Q, which is owned by Memorial Sloan Kettering Cancer Center, and receives a portion of the licensing fees (royalty payments) when the BREAST-Q is used in industry-sponsored clinical trials. Dr. Dayan is a consultant for Stryker. Dr. Mehrara is a consultant for PureTech Corporation. The remaining authors declare no conflicts of interest.

Références

American Society of Plastic Surgeons. 2018 plastic surgery statistics report. Available at: https://www.plasticsurgery.org/documents/News/Statistics/2018/plastic-surgery-statistics-full-report-2018.pdf . Accessed April 7, 2020.
Clemens MW, Miranda RN. Coming of age: Breast implant-associated anaplastic large cell lymphoma after 18 years of investigation. Clin Plast Surg. 2015;42:605–613.
U.S. Food and Drug Administration. Allergan voluntarily recalls BIOCELL textured breast implants and tissue expanders. Available at: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/allergan-voluntarily-recalls-biocellr-textured-breast-implants-and-tissue-expanders . Accessed April 7, 2020.
Carr LW, Roberts J, Potochny JD. How breast implant surface type is influenced by breast implant-associated anaplastic large cell lymphoma: A survey of the American Society of Plastic Surgeons. Ann Plast Surg. 2019;82(Suppl 3):S208–S211.
Tandon VJ, DeLong MR, Ballard TN, et al. Evolving trends in textured implant use for cosmetic augmentation in the United States. Plast Reconstr Surg. 2018;142:1456–1461.
U.S. Food and Drug Administration. The FDA requests Allergan voluntarily recall Natrelle BIOCELL textured breast implants and tissue expanders from the market to protect patients: FDA safety communication. Available at: https://www.fda.gov/medical-devices/safety-communications/fda-requests-allergan-voluntarily-recall-natrelle-biocell-textured-breast-implants-and-tissue . Accessed April 7, 2020.
McGuire PA, Deva AK, Glicksman CA, Adams WP Jr, Haws MJ. Management of asymptomatic patients with textured surface breast implants. Aesthet Surg J Open Forum2019;1:ojz025.
Lapid O, Noels EC, Meijer SL. Pathologic findings in primary capsulectomy specimens: Analysis of 2531 patients. Aesthet Surg J. 2014;34:714–718.
Barnsley GP, Sigurdson LJ, Barnsley SE. Textured surface breast implants in the prevention of capsular contracture among breast augmentation patients: A meta-analysis of randomized controlled trials. Plast Reconstr Surg. 2006;117:2182–2190.
Calobrace MB, Capizzi PJ. The biology and evolution of cohesive gel and shaped implants. Plast Reconstr Surg. 2014;134(Suppl):6S–11S.
Calobrace MB, Schwartz MR, Zeidler KR, Pittman TA, Cohen R, Stevens WG. Long-term safety of textured and smooth breast implants. Aesthet Surg J. 2017;38:38–48.
Maxwell GP, Scheflan M, Spear S, Nava MB, Hedén P. Benefits and limitations of macrotextured breast implants and consensus recommendations for optimizing their effectiveness. Aesthet Surg J. 2014;34:876–881.
Maxwell GP, Van Natta BW, Bengtson BP, et al. Ten-year results from the Natrelle 410 anatomical form-stable silicone breast implant core study. Aesthet Surg J. 2015;35:145–155.
Somogyi RB, Brown MH. Outcomes in primary breast augmentation: A single surgeon’s review of 1539 consecutive cases. Plast Reconstr Surg. 2015;135:87–97.
Adams WP Jr, Mallucci P. Breast augmentation. Plast Reconstr Surg. 2012;130:597e–611e.
Mallucci P. Discussion: Intraoperative comparison of anatomical versus round implants in breast augmentation: A randomized controlled trial. Plast Reconstr Surg. 2017;139:599–600.
Adams WP Jr, Culbertson EJ, Deva AK, et al. Macrotextured breast implants with defined steps to minimize bacterial contamination around the device: Experience in 42,000 implants. Plast Reconstr Surg. 2017;140:427–431.
Antony AK, McCarthy C, Disa JJ, Mehrara BJ. Bilateral implant breast reconstruction: Outcomes, predictors, and matched cohort analysis in 730 2-stage breast reconstructions over 10 years. Ann Plast Surg. 2014;72:625–630.
Shauly O, Gould DJ, Patel KM. Microtexture and the cell/biomaterial interface: A systematic review and meta-analysis of capsular contracture and prosthetic breast implants. Aesthet Surg J. 2019;39:603–614.
Hakelius L, Ohlsén L. A clinical comparison of the tendency to capsular contracture between smooth and textured gel-filled silicone mammary implants. Plast Reconstr Surg. 1992;90:247–254.
Pollock H. Breast capsular contracture: A retrospective study of textured versus smooth silicone implants. Plast Reconstr Surg. 1993;91:404–407.
Macadam SA, Ho AL, Lennox PA, Pusic AL. Patient-reported satisfaction and health-related quality of life following breast reconstruction: A comparison of shaped cohesive gel and round cohesive gel implant recipients. Plast Reconstr Surg. 2013;131:431–441.
Agochukwu-Nwubah N, Boustany A, Wetzel M, et al. Anatomic implants in breast reconstruction: A comparison of outcomes and aesthetic results compared to smooth round silicone implants. Aesthet Surg J. 2019;39:NP322–NP330.
Buonomo OC, Morando L, Materazzo M, et al. Comparison of round smooth and shaped micro-textured implants in terms of quality of life and aesthetic outcomes in women undergoing breast reconstruction: A single-centre prospective study. Updates Surg. 2020;72:537–546.
Khavanin N, Clemens MW, Pusic AL, et al. Shaped versus round implants in breast reconstruction: A multi-institutional comparison of surgical and patient-reported outcomes. Plast Reconstr Surg. 2017;139:1063–1070.
Voineskos SH, Klassen AF, Cano SJ, Pusic AL, Gibbons CJ. Giving meaning to differences in BREAST-Q scores: Minimal important difference for breast reconstruction patients. Plast Reconstr Surg. 2020;145:11e–20e.
Macadam SA, Ho AL, Cook EF Jr, Lennox PA, Pusic AL. Patient satisfaction and health-related quality of life following breast reconstruction: Patient-reported outcomes among saline and silicone implant recipients. Plast Reconstr Surg. 2010;125:761–771.
Calobrace MB, Stevens WG, Capizzi PJ, Cohen R, Godinez T, Beckstrand M. Risk factor analysis for capsular contracture: A 10-year Sientra study using round, smooth, and textured implants for breast augmentation. Plast Reconstr Surg. 2018;141(Sientra Shaped and Round Cohesive Gel Implants):20S–28S.
Pantelides NM, Srinivasan JR. Rippling following breast augmentation or reconstruction: Aetiology, emerging treatment options and a novel classification of severity. Aesthetic Plast Surg. 2018;42:980–985.
Sigalove S, Maxwell GP, Gabriel A. Outcomes utilizing Inspira implants in revisionary reconstructive surgery. Plast Reconstr Surg. 2019;144(Utilizing a Spectrum of Cohesive Implants in Aesthetic and Reconstructive Breast Surgery):66S–72S.
Panettiere P, Marchetti L, Accorsi D. Soft cohesive silicone gel breast prostheses: A comparative prospective study of aesthetic results versus lower cohesivity silicone gel prostheses. J Plast Reconstr Aesthet Surg. 2007;60:482–489.
Jones P, Mempin M, Hu H, et al. The functional influence of breast implant outer shell morphology on bacterial attachment and growth. Plast Reconstr Surg. 2018;142:837–849.

Auteurs

Joshua Vorstenbosch (J)

From the Plastic and Reconstructive Surgery Service, Department of Surgery, Memorial Sloan Kettering Cancer Center.

Colleen M McCarthy (CM)

From the Plastic and Reconstructive Surgery Service, Department of Surgery, Memorial Sloan Kettering Cancer Center.

Meghana G Shamsunder (MG)

From the Plastic and Reconstructive Surgery Service, Department of Surgery, Memorial Sloan Kettering Cancer Center.

Thais O Polanco (TO)

From the Plastic and Reconstructive Surgery Service, Department of Surgery, Memorial Sloan Kettering Cancer Center.

Stefan Dabic (S)

From the Plastic and Reconstructive Surgery Service, Department of Surgery, Memorial Sloan Kettering Cancer Center.

Itay Wiser (I)

From the Plastic and Reconstructive Surgery Service, Department of Surgery, Memorial Sloan Kettering Cancer Center.

Evan Matros (E)

From the Plastic and Reconstructive Surgery Service, Department of Surgery, Memorial Sloan Kettering Cancer Center.

Joseph Dayan (J)

From the Plastic and Reconstructive Surgery Service, Department of Surgery, Memorial Sloan Kettering Cancer Center.

Joseph J Disa (JJ)

From the Plastic and Reconstructive Surgery Service, Department of Surgery, Memorial Sloan Kettering Cancer Center.

Andrea L Pusic (AL)

From the Plastic and Reconstructive Surgery Service, Department of Surgery, Memorial Sloan Kettering Cancer Center.

Michele R Cavalli (MR)

From the Plastic and Reconstructive Surgery Service, Department of Surgery, Memorial Sloan Kettering Cancer Center.

Elizabeth Encarnacion (E)

From the Plastic and Reconstructive Surgery Service, Department of Surgery, Memorial Sloan Kettering Cancer Center.

Meghan Lee (M)

From the Plastic and Reconstructive Surgery Service, Department of Surgery, Memorial Sloan Kettering Cancer Center.

Babak J Mehrara (BJ)

From the Plastic and Reconstructive Surgery Service, Department of Surgery, Memorial Sloan Kettering Cancer Center.

Jonas A Nelson (JA)

From the Plastic and Reconstructive Surgery Service, Department of Surgery, Memorial Sloan Kettering Cancer Center.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH